Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Finerenone and Kidney Outcomes in Patients with Heart Failure: The FINEARTS-HF Trial.
Mc Causland FR, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS, Henderson AD, Brinker M, Perkins R, Scheerer MF, Schloemer P, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, McMurray JJV, Solomon SD. Mc Causland FR, et al. Among authors: jhund ps. J Am Coll Cardiol. 2024 Oct 22:S0735-1097(24)10252-5. doi: 10.1016/j.jacc.2024.10.091. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 39490700 Free article.
Author Correction: Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes.
Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, Brinker M, Kolkhof P, Schloemer P, Lay-Flurrie J, Viswanathan P, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD. Vaduganathan M, et al. Among authors: jhund ps. Nat Med. 2024 Oct 28. doi: 10.1038/s41591-024-03372-1. Online ahead of print. Nat Med. 2024. PMID: 39468366 No abstract available.
Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
Shen L, Dewan P, Ferreira JP, Cunningham JW, Jhund PS, Anand IS, Chandra A, Chiang LM, Claggett B, Desai AS, Gong J, Lam CSP, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Solomon SD, McMurray JJV. Shen L, et al. Among authors: jhund ps. Circulation. 2024 Oct 21. doi: 10.1161/CIRCULATIONAHA.124.070553. Online ahead of print. Circulation. 2024. PMID: 39429145
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF Trials.
Lu H, Claggett BL, Packer M, Pabon MA, Pfeffer MA, Lewis EF, Lam CSP, Rouleau J, Zile MR, Lefkowitz M, Desai AS, Jhund PS, McMurray JJV, Solomon SD, Vaduganathan M. Lu H, et al. Among authors: jhund ps. JACC Heart Fail. 2024 Aug 31:S2213-1779(24)00609-7. doi: 10.1016/j.jchf.2024.08.008. Online ahead of print. JACC Heart Fail. 2024. PMID: 39387766
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial.
Desai AS, Vaduganathan M, Claggett BL, Kulac IJ, Jhund PS, Cunningham J, Borentain M, Lay-Flurrie J, Viswanathan P, Rohwedder K, Amarante F, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Kosiborod M, McMurray JJV, Solomon SD. Desai AS, et al. Among authors: jhund ps. J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08452-3. doi: 10.1016/j.jacc.2024.09.004. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 39352340 Free article.
Time to Significant Benefit of Finerenone in Patients With Heart Failure.
Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, McMurray JJ, Solomon SD. Vaduganathan M, et al. Among authors: jhund ps. J Am Coll Cardiol. 2024 Sep 26:S0735-1097(24)08512-7. doi: 10.1016/j.jacc.2024.09.018. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 39352338 Free article. No abstract available.
Finerenone Improves Outcomes in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF.
Chimura M, Petrie MC, Schou M, Martinez FA, Henderson AD, Claggett BL, Desai AS, Kolkhof P, Viswanathan P, Lage A, Lam CSP, Senni M, Shah SJ, Rohwedder K, Mueller K, Voors AA, Zannad F, Pitt B, Vaduganathan M, Jhund PS, Solomon S, McMurray JJV. Chimura M, et al. Among authors: jhund ps. Circ Heart Fail. 2024 Sep 29. doi: 10.1161/CIRCHEARTFAILURE.124.012437. Online ahead of print. Circ Heart Fail. 2024. PMID: 39342655 Free article.
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure with Mildly Reduced and Preserved Ejection Fraction: a Prespecified Analysis of The FINEARTS-HF Trial.
Docherty KF, Henderson AD, Jhund PS, Claggett BL, Desai AS, Mueller K, Viswanathan P, Scalise A, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJ. Docherty KF, et al. Among authors: jhund ps. Circulation. 2024 Sep 29. doi: 10.1161/CIRCULATIONAHA.124.072011. Online ahead of print. Circulation. 2024. PMID: 39342512 Free article.
400 results